Arizona, Florida, Nebraska, Ohio, and Wisconsin join the complaint alleging the company misled consumers about data privacy.
Arizona, Florida, Nebraska, Ohio, and Wisconsin join the complaint alleging the company misled consumers about data privacy.
A Maryland judge blocked CMS’s ACA broker registration freeze, allowing new agents to train and participate in open enrollment this season.
Four states are suing the HHS over Medicaid work requirements, arguing the CMS did not have constitutional authority to impose them.
The warning for NAION risk applies to all GLP-1 medications, including popular weight loss drugs Ozempic, Wegovy, Mounjaro, and Zepbound.
Agency says no remotely teleoperated or fully autonomous robotic devices have received US authorization to be marketed.
FDA asked to build on regulatory mechanisms rather than invent a new framework to accommodate the emerging technology.
Our in-brief roundup of notable healthcare and life sciences stories from the last two weeks.
CMS to select up to 20 additional drugs covered under Part D and/or payable under Part B, plus select drugs for price renegotiation.